Dermatosurgical rounds: shark island pedicle flap for skin defect of the alar crease area after basal cell carcinoma removal
Accepted: 23 September 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
A 67-year-old female presented to the Dermatology Department with a tumor formation located on the left lateral side wall of the nose, measuring 1,5/1,2 cm in size, which had been slowly growing over the past few years. The tumor exhibited a shiny, pink-colored surface with a dome-shaped appearance, irregular borders, and superficial telangiectasias, raising clinical suspicion for basal cell carcinoma. Additionally, there was no reported history of skin cancer in any family member or painful sunburns during childhood. The patient was recommended surgical excision under local anesthesia for the suspected lesion.
Kim Y, Decker A, Lawrence N. How we do it: shark island pedicle flap for alar crease defects. Dermatol Surg 2024;50:293-4. DOI: https://doi.org/10.1097/DSS.0000000000004058
Pérez-Paredes MG, Valladares Narganes LM, Cucunubo HA, Rodríguez Prieto MÁ. Shark island flap for reconstruction of nasal ala-perinasal defects. Actas Dermosifiliogr 2014;105:709-11. DOI: https://doi.org/10.1016/j.adengl.2014.07.008
Cvancara JL, Wentzell JM. Shark island pedicle flap for repair of combined nasal ala-perialar defects. Dermatol Surg 2006;32:726-9. DOI: https://doi.org/10.1111/j.1524-4725.2006.32146.x
Volz A, Frauenknecht V, Häusermann P. Shark island pedicle flap for reconstruction of the lateral nasal ala and perialar defects. J Dtsch Dermatol Ges 2018;16:108-11. DOI: https://doi.org/10.1111/ddg.13397_g
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.